Cannara Biotech Inc. (TSXV:LOVE)
Canada
· Delayed Price · Currency is CAD 1.290
+0.040 (3.20%)
Feb 21, 2025, 3:55 PM EST
Cannara Biotech Revenue
Cannara Biotech had revenue of 24.95M CAD in the quarter ending November 30, 2024, with 28.46% growth. This brings the company's revenue in the last twelve months to 87.28M, up 31.35% year-over-year. In the fiscal year ending August 31, 2024, Cannara Biotech had annual revenue of 81.75M with 42.77% growth.
Revenue (ttm)
87.28M
Revenue Growth
+31.35%
P/S Ratio
1.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
116.93M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| dentalcorp Holdings | 1.51B |
| WELL Health Technologies | 957.69M |
| Curaleaf Holdings | 1.83B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.58B |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |